Disease: Quebec platelet disorder
- 1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular events
- 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
- A case of Quebec platelet disorder with interstitial pneumonia
- A Comprehensive Review of Congenital Platelet Disorders, Thrombocytopenias and Thrombocytopathies
- Abnormal differentiation of B cells and megakaryocytes in patients with Roifman syndrome
- Acquired thrombotic thrombocytopenic purpura with isolated CFHR3/1 deletion-rapid remission following complement blockade
- Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry
- Antithrombotic thrombocytes: ectopic expression of urokinase-type plasminogen activator in platelets
- Bleeding risks associated with inheritance of the Quebec platelet disorder
- Blood Disorders in Patients Undergoing Transcatheter Aortic Valve Replacement: A Review
- Breaking barriers: Quebec platelet disorder
- Challenges in diagnosis of von Willebrand disease in the presence of combined mutations of different genes
- Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia
- Clinical importance of thrombocytopenia in patients with acute coronary syndromes: a systematic review and meta-analysis
- Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: Communication from the ISTH SSC Subcommittee on Platelet Physiology
- Current Strategies in Diagnosis of Inherited Storage Pool Defects
- Diagnosis and Management of Acquired von Willebrand Disease in Heart Disease: A Review of the Literature
- Diagnostic assessment of platelet disorders: what are the challenges to standardization?
- Differential correlation of serum BDNF and microRNA content in rats with rapid or late onset of heavy alcohol use
- Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature
- Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
- Enhancer-gene rewiring in the pathogenesis of Quebec platelet disorder
- Erratum: Quebec Platelet Disorder: Update on Pathogenesis, Diagnosis, and Treatment
- Evaluation of urokinase plasminogen activator in urine from individuals with Quebec platelet disorder
- Evolution and Impact of Thrombocytopenia in Septic Shock: A Retrospective Cohort Study
- Expert opinion on the use of platelet secretion assay for the diagnosis of inherited platelet function disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology
- Extreme thrombocytosis in low-risk essential thrombocythemia: Retrospective review of vascular events and treatment strategies
- False-Positive Syphilis Serologies in a Woman Receiving Intravenous Immunoglobulin
- Fibrinolysis and bleeding of unknown cause
- Genetic abnormalities in biopsy-proven, adult-onset hemolytic uremic syndrome and C3 glomerulopathy
- Genotypic analysis of a large cohort of patients with suspected atypical hemolytic uremic syndrome
- Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies
- High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML
- Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress
- Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry&quo
- Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia
- Impaired platelet procoagulant mechanisms in patients with bleeding disorders
- Improved platelet counts during prolonged tranexamic therapy for Quebec platelet disorder implicate the underlying fibrinolytic defect as the cause of lower platelet counts
- Improving blood disorder diagnosis: reflections on the challenges
- Incidence and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm and term gestation: a population-based study
- Incidence of thrombotic microangiopathies in Quebec: insight from a laboratory centralizing ADAMTS-13 testing
- Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation
- Inherited disorders of platelet alpha-granules
- Inherited disorders of the fibrinolytic pathway
- Inherited Kidney Complement Diseases
- Inherited trombophilic states and pulmonary embolism
- Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis
- Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder
- Laboratory testing for bleeding disorders: strategic uses of high and low-yield tests
- Live imaging of platelets and neutrophils during antibody-mediated neurovascular thrombosis
- Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden
- Long VITT: A case report
- Management of a Left Atrial Appendage Thrombus Due to Atrial Fibrillation Complicating Quebec Platelet Disorder
- Management of Quebec Platelet Disorder for Cervical Facet Injections in the Outpatient Setting: A Case Report
- Monoclonal gammopathy-associated thrombotic microangiopathy
- Neurological Involvement in Childhood Evans Syndrome
- Origins of oscillation patterns in cyclical thrombocytopenia
- Pathology of Gastrointestinal and Liver Complications of Hematopoietic Stem Cell Transplantation
- Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale
- Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia
- Persisting autoimmune heparin-induced thrombocytopenia after elective abdominal aortic aneurysm repair: a case report
- Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene
- Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates
- Physician decision making in selection of second-line treatments in immune thrombocytopenia in children
- Platelet abnormalities in Huntington's disease
- Platelet factor V New York: a defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation
- Platelet-delivered therapeutics
- Platelet-derived extracellular vesicles in Huntington's disease
- Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator
- Predicting Adverse Outcomes for Shiga Toxin-Producing Escherichia coli Infections in Emergency Departments
- Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children
- Proteomics applied to the study of platelet-related diseases: aiding the discovery of novel platelet biomarkers and drug targets
- Quality of life is an important indication for second-line treatment in children with immune thrombocytopenia
- Quebec platelet disorder
- Quebec platelet disorder
- Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes
- Quebec platelet disorder: features, pathogenesis and treatment
- Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment
- Rare inherited coagulation and fibrinolytic defects that challenge diagnostic laboratories
- Refractory immune TTP following Pfizer-BioNTech COVID-19 vaccine successfully salvaged with caplacizumab
- Renal Thrombotic Microangiopathy: A Review
- Reported prevalence of von Willebrand disease worldwide in relation to income classification
- Residual risks of bacterial contamination for pathogen-reduced platelet components
- Risk of infection in MPN patients in the era of Covid-19: A prospective multicenter study of 257 patients from the CML-MPN Quebec Research Group
- Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes
- Simultaneous measurement of adenosine triphosphate release and aggregation potentiates human platelet aggregation responses for some subjects, including persons with Quebec platelet disorder
- Site-specific venous thrombosis in essential thrombocythemia: Impact on subsequent vascular events and survival
- Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT): COMMENT from Roberge, et al
- The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes
- The value of proteomics for the diagnosis of a platelet-related bleeding disorder
- Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia
- Thrombin generation abnormalities in Quebec platelet disorder
- Thrombocytopenia and neonatal outcomes among extremely premature infants exposed to maternal hypertension
- Thrombopoietin levels in Quebec platelet disorder-Implications for the mechanism of thrombocytopenia
- Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin
- Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review
- Volanesorsen and Triglyceride LevelsĀ in Familial Chylomicronemia Syndrome
- Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial
- Von Willebrand Disease: Gaining a global perspective
- Young platelet millionaires with essential thrombocythemia